PDK LABS INC
10-Q, EX-27, 2000-10-13
PHARMACEUTICAL PREPARATIONS
Previous: PDK LABS INC, 10-Q, 2000-10-13
Next: DYNAGEN INC, S-3/A, 2000-10-13



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<MULTIPLIER>                                   1000

<S>                             <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                        NOV-30-2000
<PERIOD-END>                             AUG-31-2000
<CASH>                                           213
<SECURITIES>                                   5,999
<RECEIVABLES>                                 12,296
<ALLOWANCES>                                      54
<INVENTORY>                                    6,776
<CURRENT-ASSETS>                              28,092
<PP&E>                                        12,091
<DEPRECIATION>                                 9,032
<TOTAL-ASSETS>                                34,989
<CURRENT-LIABILITIES>                          1,689
<BONDS>                                        1,446
                              0
                                        5
<COMMON>                                          38
<OTHER-SE>                                    29,769
<TOTAL-LIABILITY-AND-EQUITY>                  34,989
<SALES>                                       36,282
<TOTAL-REVENUES>                              36,282
<CGS>                                         25,008
<TOTAL-COSTS>                                 25,008
<OTHER-EXPENSES>                                   0
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                               179
<INCOME-PRETAX>                                2,233
<INCOME-TAX>                                     834
<INCOME-CONTINUING>                            1,420
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                   1,420
<EPS-BASIC>                                      .54
<EPS-DILUTED>                                    .54



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission